Original Article
Disease control in patients with psoriatic arthritis in real clinical practice in Spain: MiDAS study
Control de la enfermedad en pacientes con artritis psoriásica en práctica clínica real en España: estudio MiDAS
Jordi Gratacósa, José L. Pablosb, Eugenio de Miguelc, Xavier Juanolad, Cristina Fernández-Carballidoe, Rafael Arizaf, Pau Terradas-Montanag, Carlos Sastrég,
, Cristina Sanabrag, MiDAS Group
Corresponding author
a Rheumatology Department, Hospital Universitario Parc Taulí Sabadell, Departamento Medicina UAB, Spain
b Rheumatology Department, Hospital 12 de Octubre, Madrid, Spain
c Rheumatology Department, Hospital Universitario La Paz, Madrid, Spain
d Rheumatology Department, Hospital Universitari Bellvitge, IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain
e Rheumatology Department, Hospital Universitario San Juan de Alicante, Alicante, Spain
f Rheumatology Department, Hospital Universitario Virgen de Macarena, Sevilla, Spain
g Novartis Farmacéutica, Barcelona, Spain
Read
3539
Timeswas read the article
1291
Total PDF
2248
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 407 | 165 | 572 |
| 2025 11 | 393 | 53 | 446 |
| 2025 10 | 30 | 64 | 94 |
| 2025 9 | 0 | 49 | 49 |
| 2025 8 | 1 | 71 | 72 |
| 2025 7 | 0 | 65 | 65 |
| 2025 6 | 1 | 49 | 50 |
| 2025 5 | 137 | 56 | 193 |
| 2025 4 | 117 | 40 | 157 |
| 2025 3 | 102 | 34 | 136 |
| 2025 2 | 85 | 53 | 138 |
| 2025 1 | 68 | 35 | 103 |
| 2024 12 | 52 | 30 | 82 |
| 2024 11 | 81 | 66 | 147 |
| 2024 10 | 47 | 24 | 71 |
| 2024 9 | 34 | 17 | 51 |
| 2024 8 | 60 | 38 | 98 |
| 2024 7 | 68 | 35 | 103 |
| 2024 6 | 95 | 36 | 131 |
| 2024 5 | 63 | 48 | 111 |
| 2024 4 | 57 | 46 | 103 |
| 2024 3 | 52 | 31 | 83 |
| 2024 2 | 51 | 26 | 77 |
| 2024 1 | 33 | 21 | 54 |
| 2023 12 | 35 | 34 | 69 |
| 2023 11 | 59 | 50 | 109 |
| 2023 10 | 83 | 37 | 120 |
| 2023 9 | 16 | 1 | 17 |
| 2023 8 | 2 | 0 | 2 |
| 2023 5 | 1 | 1 | 2 |
| 2023 4 | 6 | 3 | 9 |
| 2023 3 | 5 | 7 | 12 |
| 2023 2 | 3 | 2 | 5 |
| 2022 12 | 1 | 2 | 3 |
| 2022 7 | 3 | 2 | 5 |
Show all
